Exane Derivatives’s ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX) MTCN Stock Holding History

Exane Derivatives’s Portfolio MTCN Stock Details MTCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,275	Closed	–	–	629
2015 Q4	$0	Hold	5,275	–	–	﹤0.01%	589
2015 Q3	$44.3K	Hold	5,275	–	–	0.01%	280
2015 Q2	$83.1K	Buy	5,275 +1,150	+28%	+$19.5K	0.01%	262
2015 Q1	$39.8K	Sell	4,125 -1,300	-24%	-$21.5K	﹤0.01%	330
2014 Q4	$96.4K	Buy	+5,425	New	+$105K	0.01%	285

Exane Derivatives's MTCN Position: Q1 2016 in Review

Exane Derivatives sold out of ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX) (MTCN) in Q1 2016, closing a stake of 5,275 shares.

Exane Derivatives first reported a position in MTCN in Q4 2014 and held it in 5 quarters. The position peaked at $96.4K in Q4 2014. 0 funds tracked by Wall St. Rank hold MTCN as of Q1 2016.

Exane Derivatives reported no remaining ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX) position as of Q1 2016 after selling out during the quarter.
Exane Derivatives sold 5,275 ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX) shares in Q1 2016.
Exane Derivatives first reported a position in ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX) in Q4 2014 and held it in 5 quarters.
Exane Derivatives's ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX) position peaked at $96.4K in Q4 2014.
0 funds tracked by Wall St. Rank held ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX) as of Q1 2016.

Based on Exane Derivatives's 13F filing for Q1 2016, filed 4 May 2016.